Harman Finochem Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PHENYTOIN SODIUM USP, with a corresponding US DMF Number 17862.
Remarkably, this DMF maintains an Active status since its submission on December 02, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 14, 2015, and payment made on September 30, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II